nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—SLC12A3—Cation-coupled Chloride cotransporters—SLC12A5—epilepsy syndrome	0.0815	0.271	CbGpPWpGaD
Polythiazide—SLC12A3—Cation-coupled Chloride cotransporters—SLC12A2—epilepsy syndrome	0.0468	0.156	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.0101	0.0336	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00925	0.0308	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00767	0.0255	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00767	0.0255	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00731	0.0243	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00581	0.0193	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00581	0.0193	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00531	0.0177	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00494	0.0164	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00452	0.015	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00452	0.015	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00452	0.015	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00435	0.0145	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.0042	0.014	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00413	0.0137	CbGpPWpGaD
Polythiazide—Quinethazone—SLC12A2—epilepsy syndrome	0.00405	0.151	CrCbGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00343	0.0114	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00343	0.0114	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00343	0.0114	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00327	0.0109	CbGpPWpGaD
Polythiazide—Bendroflumethiazide—KCNMA1—epilepsy syndrome	0.00299	0.111	CrCbGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.00266	0.00886	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.0026	0.00863	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.0026	0.00863	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00258	0.00857	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00258	0.00857	CbGpPWpGaD
Polythiazide—Bendroflumethiazide—CA4—epilepsy syndrome	0.00243	0.0902	CrCbGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.00237	0.00789	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.0023	0.00764	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.0023	0.00764	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.0023	0.00764	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.00221	0.00734	CbGpPWpGaD
Polythiazide—Hydroflumethiazide—KCNMA1—epilepsy syndrome	0.00213	0.0793	CrCbGaD
Polythiazide—Methyclothiazide—CA4—epilepsy syndrome	0.00213	0.0791	CrCbGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.0021	0.00698	CbGpPWpGaD
Polythiazide—Hydrochlorothiazide—KCNMA1—epilepsy syndrome	0.00208	0.0771	CrCbGaD
Polythiazide—Cyclothiazide—CA4—epilepsy syndrome	0.00206	0.0767	CrCbGaD
Polythiazide—Benzthiazide—CA4—epilepsy syndrome	0.00206	0.0767	CrCbGaD
Polythiazide—Chlorothiazide—CA4—epilepsy syndrome	0.00205	0.0762	CrCbGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.00194	0.00646	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.00188	0.00624	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.00184	0.0061	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.00174	0.00579	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.00174	0.00579	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.00174	0.00579	CbGpPWpGaD
Polythiazide—Hydroflumethiazide—CA4—epilepsy syndrome	0.00173	0.0643	CrCbGaD
Polythiazide—Hydrochlorothiazide—CA4—epilepsy syndrome	0.00168	0.0625	CrCbGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.00167	0.00556	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00166	0.00552	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00166	0.00552	CbGpPWpGaD
Polythiazide—Trichlormethiazide—CA4—epilepsy syndrome	0.0015	0.0557	CrCbGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00135	0.0045	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.00132	0.00439	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.00132	0.00439	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.00126	0.00418	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.00121	0.00402	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.00121	0.00401	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.00121	0.00401	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.00121	0.00401	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.00121	0.00401	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.00112	0.00373	CbGpPWpGaD
Polythiazide—Dermatitis—Lacosamide—epilepsy syndrome	0.00107	0.0016	CcSEcCtD
Polythiazide—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.00107	0.00159	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.00107	0.00356	CbGpPWpGaD
Polythiazide—Headache—Lacosamide—epilepsy syndrome	0.00107	0.00159	CcSEcCtD
Polythiazide—Anorexia—Clonazepam—epilepsy syndrome	0.00107	0.00159	CcSEcCtD
Polythiazide—Decreased appetite—Diazepam—epilepsy syndrome	0.00107	0.00158	CcSEcCtD
Polythiazide—Paraesthesia—Felbamate—epilepsy syndrome	0.00106	0.00158	CcSEcCtD
Polythiazide—Constipation—Vigabatrin—epilepsy syndrome	0.00106	0.00158	CcSEcCtD
Polythiazide—Urticaria—Midazolam—epilepsy syndrome	0.00106	0.00158	CcSEcCtD
Polythiazide—Anorexia—Phenytoin—epilepsy syndrome	0.00106	0.00158	CcSEcCtD
Polythiazide—Asthenia—Acetazolamide—epilepsy syndrome	0.00106	0.00157	CcSEcCtD
Polythiazide—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.00106	0.00157	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.00105	0.00351	CbGpPWpGaD
Polythiazide—Anorexia—Oxcarbazepine—epilepsy syndrome	0.00105	0.00157	CcSEcCtD
Polythiazide—Vomiting—Clobazam—epilepsy syndrome	0.00105	0.00156	CcSEcCtD
Polythiazide—Constipation—Diazepam—epilepsy syndrome	0.00105	0.00156	CcSEcCtD
Polythiazide—Rash—Clobazam—epilepsy syndrome	0.00104	0.00155	CcSEcCtD
Polythiazide—Paraesthesia—Zonisamide—epilepsy syndrome	0.00104	0.00155	CcSEcCtD
Polythiazide—Dermatitis—Clobazam—epilepsy syndrome	0.00104	0.00155	CcSEcCtD
Polythiazide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.00104	0.00154	CcSEcCtD
Polythiazide—Headache—Clobazam—epilepsy syndrome	0.00104	0.00154	CcSEcCtD
Polythiazide—Jaundice—Gabapentin—epilepsy syndrome	0.00103	0.00154	CcSEcCtD
Polythiazide—Decreased appetite—Felbamate—epilepsy syndrome	0.00103	0.00153	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.00103	0.00341	CbGpPWpGaD
Polythiazide—Urticaria—Fosphenytoin—epilepsy syndrome	0.00101	0.00151	CcSEcCtD
Polythiazide—Constipation—Felbamate—epilepsy syndrome	0.00101	0.00151	CcSEcCtD
Polythiazide—Nausea—Lacosamide—epilepsy syndrome	0.00101	0.00151	CcSEcCtD
Polythiazide—Anorexia—Carbamazepine—epilepsy syndrome	0.00101	0.0015	CcSEcCtD
Polythiazide—Decreased appetite—Zonisamide—epilepsy syndrome	0.00101	0.0015	CcSEcCtD
Polythiazide—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00101	0.0015	CcSEcCtD
Polythiazide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.001	0.00149	CcSEcCtD
Polythiazide—Paraesthesia—Phenytoin—epilepsy syndrome	0.000998	0.00148	CcSEcCtD
Polythiazide—Constipation—Zonisamide—epilepsy syndrome	0.000993	0.00148	CcSEcCtD
Polythiazide—Urticaria—Vigabatrin—epilepsy syndrome	0.000989	0.00147	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000988	0.00328	CbGpPWpGaD
Polythiazide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000987	0.00147	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000986	0.00328	CbGpPWpGaD
Polythiazide—Nausea—Clobazam—epilepsy syndrome	0.000982	0.00146	CcSEcCtD
Polythiazide—Asthenia—Propofol—epilepsy syndrome	0.000982	0.00146	CcSEcCtD
Polythiazide—Pancreatitis—Topiramate—epilepsy syndrome	0.00098	0.00146	CcSEcCtD
Polythiazide—Anorexia—Lamotrigine—epilepsy syndrome	0.000977	0.00145	CcSEcCtD
Polythiazide—Dizziness—Acetazolamide—epilepsy syndrome	0.000975	0.00145	CcSEcCtD
Polythiazide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000975	0.00145	CcSEcCtD
Polythiazide—Urticaria—Diazepam—epilepsy syndrome	0.000973	0.00145	CcSEcCtD
Polythiazide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000973	0.00145	CcSEcCtD
Polythiazide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000966	0.00144	CcSEcCtD
Polythiazide—Asthenia—Midazolam—epilepsy syndrome	0.000961	0.00143	CcSEcCtD
Polythiazide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000961	0.00143	CcSEcCtD
Polythiazide—Muscle spasms—Valproic Acid—epilepsy syndrome	0.00096	0.00143	CcSEcCtD
Polythiazide—Constipation—Clonazepam—epilepsy syndrome	0.000957	0.00142	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000954	0.00317	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000954	0.00317	CbGpPWpGaD
Polythiazide—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000953	0.00142	CcSEcCtD
Polythiazide—Constipation—Phenytoin—epilepsy syndrome	0.00095	0.00141	CcSEcCtD
Polythiazide—Asthenia—Levetiracetam—epilepsy syndrome	0.000949	0.00141	CcSEcCtD
Polythiazide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000945	0.00141	CcSEcCtD
Polythiazide—Urticaria—Felbamate—epilepsy syndrome	0.000942	0.0014	CcSEcCtD
Polythiazide—Vomiting—Acetazolamide—epilepsy syndrome	0.000937	0.00139	CcSEcCtD
Polythiazide—Diarrhoea—Propofol—epilepsy syndrome	0.000937	0.00139	CcSEcCtD
Polythiazide—Headache—Acetazolamide—epilepsy syndrome	0.000924	0.00137	CcSEcCtD
Polythiazide—Urticaria—Zonisamide—epilepsy syndrome	0.000922	0.00137	CcSEcCtD
Polythiazide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000922	0.00137	CcSEcCtD
Polythiazide—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000921	0.00137	CcSEcCtD
Polythiazide—Agitation—Valproic Acid—epilepsy syndrome	0.000917	0.00136	CcSEcCtD
Polythiazide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000917	0.00136	CcSEcCtD
Polythiazide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000916	0.00136	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000914	0.00304	CbGpPWpGaD
Polythiazide—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000912	0.00136	CcSEcCtD
Polythiazide—Constipation—Carbamazepine—epilepsy syndrome	0.000907	0.00135	CcSEcCtD
Polythiazide—Dizziness—Propofol—epilepsy syndrome	0.000905	0.00135	CcSEcCtD
Polythiazide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000905	0.00135	CcSEcCtD
Polythiazide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000903	0.00134	CcSEcCtD
Polythiazide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000901	0.00134	CcSEcCtD
Polythiazide—Vertigo—Valproic Acid—epilepsy syndrome	0.000897	0.00133	CcSEcCtD
Polythiazide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000893	0.00133	CcSEcCtD
Polythiazide—Asthenia—Vigabatrin—epilepsy syndrome	0.000893	0.00133	CcSEcCtD
Polythiazide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000891	0.00133	CcSEcCtD
Polythiazide—Urticaria—Clonazepam—epilepsy syndrome	0.000889	0.00132	CcSEcCtD
Polythiazide—Dizziness—Midazolam—epilepsy syndrome	0.000886	0.00132	CcSEcCtD
Polythiazide—Urticaria—Phenytoin—epilepsy syndrome	0.000883	0.00131	CcSEcCtD
Polythiazide—Asthenia—Diazepam—epilepsy syndrome	0.000879	0.00131	CcSEcCtD
Polythiazide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000878	0.00131	CcSEcCtD
Polythiazide—Constipation—Lamotrigine—epilepsy syndrome	0.000877	0.0013	CcSEcCtD
Polythiazide—Nausea—Acetazolamide—epilepsy syndrome	0.000876	0.0013	CcSEcCtD
Polythiazide—Dizziness—Levetiracetam—epilepsy syndrome	0.000875	0.0013	CcSEcCtD
Polythiazide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000874	0.0013	CcSEcCtD
Polythiazide—Vomiting—Propofol—epilepsy syndrome	0.000871	0.0013	CcSEcCtD
Polythiazide—Muscle spasms—Pregabalin—epilepsy syndrome	0.000868	0.00129	CcSEcCtD
Polythiazide—Rash—Propofol—epilepsy syndrome	0.000863	0.00128	CcSEcCtD
Polythiazide—Dermatitis—Propofol—epilepsy syndrome	0.000863	0.00128	CcSEcCtD
Polythiazide—Headache—Propofol—epilepsy syndrome	0.000858	0.00128	CcSEcCtD
Polythiazide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000855	0.00127	CcSEcCtD
Polythiazide—Vomiting—Midazolam—epilepsy syndrome	0.000852	0.00127	CcSEcCtD
Polythiazide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000852	0.00127	CcSEcCtD
Polythiazide—Asthenia—Felbamate—epilepsy syndrome	0.000851	0.00127	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.00085	0.00283	CbGpPWpGaD
Polythiazide—Rash—Midazolam—epilepsy syndrome	0.000845	0.00126	CcSEcCtD
Polythiazide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000844	0.00126	CcSEcCtD
Polythiazide—Dermatitis—Midazolam—epilepsy syndrome	0.000844	0.00126	CcSEcCtD
Polythiazide—Urticaria—Carbamazepine—epilepsy syndrome	0.000843	0.00125	CcSEcCtD
Polythiazide—Vomiting—Levetiracetam—epilepsy syndrome	0.000841	0.00125	CcSEcCtD
Polythiazide—Headache—Midazolam—epilepsy syndrome	0.000839	0.00125	CcSEcCtD
Polythiazide—Diarrhoea—Diazepam—epilepsy syndrome	0.000838	0.00125	CcSEcCtD
Polythiazide—Rash—Levetiracetam—epilepsy syndrome	0.000834	0.00124	CcSEcCtD
Polythiazide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000833	0.00124	CcSEcCtD
Polythiazide—Asthenia—Zonisamide—epilepsy syndrome	0.000833	0.00124	CcSEcCtD
Polythiazide—Agranulocytosis—Topiramate—epilepsy syndrome	0.000831	0.00124	CcSEcCtD
Polythiazide—Agitation—Pregabalin—epilepsy syndrome	0.000829	0.00123	CcSEcCtD
Polythiazide—Headache—Levetiracetam—epilepsy syndrome	0.000829	0.00123	CcSEcCtD
Polythiazide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000824	0.00123	CcSEcCtD
Polythiazide—Dizziness—Vigabatrin—epilepsy syndrome	0.000823	0.00122	CcSEcCtD
Polythiazide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000819	0.00122	CcSEcCtD
Polythiazide—Urticaria—Lamotrigine—epilepsy syndrome	0.000814	0.00121	CcSEcCtD
Polythiazide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000814	0.00121	CcSEcCtD
Polythiazide—Nausea—Propofol—epilepsy syndrome	0.000813	0.00121	CcSEcCtD
Polythiazide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000812	0.00121	CcSEcCtD
Polythiazide—Diarrhoea—Felbamate—epilepsy syndrome	0.000811	0.00121	CcSEcCtD
Polythiazide—Vertigo—Pregabalin—epilepsy syndrome	0.000811	0.00121	CcSEcCtD
Polythiazide—Dizziness—Diazepam—epilepsy syndrome	0.00081	0.00121	CcSEcCtD
Polythiazide—Leukopenia—Pregabalin—epilepsy syndrome	0.000808	0.0012	CcSEcCtD
Polythiazide—Rash—Fosphenytoin—epilepsy syndrome	0.000805	0.0012	CcSEcCtD
Polythiazide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000804	0.0012	CcSEcCtD
Polythiazide—Asthenia—Clonazepam—epilepsy syndrome	0.000803	0.00119	CcSEcCtD
Polythiazide—Headache—Fosphenytoin—epilepsy syndrome	0.0008	0.00119	CcSEcCtD
Polythiazide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000798	0.00119	CcSEcCtD
Polythiazide—Asthenia—Phenytoin—epilepsy syndrome	0.000797	0.00119	CcSEcCtD
Polythiazide—Nausea—Midazolam—epilepsy syndrome	0.000796	0.00118	CcSEcCtD
Polythiazide—Muscle spasms—Gabapentin—epilepsy syndrome	0.000796	0.00118	CcSEcCtD
Polythiazide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000794	0.00118	CcSEcCtD
Polythiazide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000793	0.00118	CcSEcCtD
Polythiazide—Vomiting—Vigabatrin—epilepsy syndrome	0.000791	0.00118	CcSEcCtD
Polythiazide—Nausea—Levetiracetam—epilepsy syndrome	0.000786	0.00117	CcSEcCtD
Polythiazide—Rash—Vigabatrin—epilepsy syndrome	0.000785	0.00117	CcSEcCtD
Polythiazide—Dizziness—Felbamate—epilepsy syndrome	0.000784	0.00117	CcSEcCtD
Polythiazide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000784	0.00117	CcSEcCtD
Polythiazide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000782	0.00116	CcSEcCtD
Polythiazide—Headache—Vigabatrin—epilepsy syndrome	0.00078	0.00116	CcSEcCtD
Polythiazide—Vomiting—Diazepam—epilepsy syndrome	0.000779	0.00116	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000778	0.00258	CbGpPWpGaD
Polythiazide—Anorexia—Valproic Acid—epilepsy syndrome	0.000777	0.00116	CcSEcCtD
Polythiazide—Rash—Diazepam—epilepsy syndrome	0.000773	0.00115	CcSEcCtD
Polythiazide—Dermatitis—Diazepam—epilepsy syndrome	0.000772	0.00115	CcSEcCtD
Polythiazide—Dizziness—Zonisamide—epilepsy syndrome	0.000768	0.00114	CcSEcCtD
Polythiazide—Headache—Diazepam—epilepsy syndrome	0.000768	0.00114	CcSEcCtD
Polythiazide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000765	0.00114	CcSEcCtD
Polythiazide—Asthenia—Carbamazepine—epilepsy syndrome	0.000761	0.00113	CcSEcCtD
Polythiazide—Agitation—Gabapentin—epilepsy syndrome	0.00076	0.00113	CcSEcCtD
Polythiazide—Diarrhoea—Phenytoin—epilepsy syndrome	0.00076	0.00113	CcSEcCtD
Polythiazide—Nausea—Fosphenytoin—epilepsy syndrome	0.000758	0.00113	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000758	0.00252	CbGpPWpGaD
Polythiazide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000756	0.00113	CcSEcCtD
Polythiazide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000755	0.00112	CcSEcCtD
Polythiazide—Vomiting—Felbamate—epilepsy syndrome	0.000754	0.00112	CcSEcCtD
Polythiazide—Rash—Felbamate—epilepsy syndrome	0.000748	0.00111	CcSEcCtD
Polythiazide—Dermatitis—Felbamate—epilepsy syndrome	0.000747	0.00111	CcSEcCtD
Polythiazide—Vertigo—Gabapentin—epilepsy syndrome	0.000743	0.00111	CcSEcCtD
Polythiazide—Headache—Felbamate—epilepsy syndrome	0.000743	0.00111	CcSEcCtD
Polythiazide—Leukopenia—Gabapentin—epilepsy syndrome	0.000741	0.0011	CcSEcCtD
Polythiazide—Dizziness—Clonazepam—epilepsy syndrome	0.00074	0.0011	CcSEcCtD
Polythiazide—Nausea—Vigabatrin—epilepsy syndrome	0.000739	0.0011	CcSEcCtD
Polythiazide—Vomiting—Zonisamide—epilepsy syndrome	0.000738	0.0011	CcSEcCtD
Polythiazide—Asthenia—Lamotrigine—epilepsy syndrome	0.000736	0.00109	CcSEcCtD
Polythiazide—Dizziness—Phenytoin—epilepsy syndrome	0.000735	0.00109	CcSEcCtD
Polythiazide—Rash—Zonisamide—epilepsy syndrome	0.000732	0.00109	CcSEcCtD
Polythiazide—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000732	0.00109	CcSEcCtD
Polythiazide—Dermatitis—Zonisamide—epilepsy syndrome	0.000731	0.00109	CcSEcCtD
Polythiazide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000731	0.00109	CcSEcCtD
Polythiazide—Nausea—Diazepam—epilepsy syndrome	0.000728	0.00108	CcSEcCtD
Polythiazide—Headache—Zonisamide—epilepsy syndrome	0.000727	0.00108	CcSEcCtD
Polythiazide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000726	0.00108	CcSEcCtD
Polythiazide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000721	0.00107	CcSEcCtD
Polythiazide—Vomiting—Clonazepam—epilepsy syndrome	0.000711	0.00106	CcSEcCtD
Polythiazide—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000708	0.00105	CcSEcCtD
Polythiazide—Vomiting—Phenytoin—epilepsy syndrome	0.000707	0.00105	CcSEcCtD
Polythiazide—Rash—Clonazepam—epilepsy syndrome	0.000705	0.00105	CcSEcCtD
Polythiazide—Dermatitis—Clonazepam—epilepsy syndrome	0.000705	0.00105	CcSEcCtD
Polythiazide—Nausea—Felbamate—epilepsy syndrome	0.000704	0.00105	CcSEcCtD
Polythiazide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000703	0.00105	CcSEcCtD
Polythiazide—Anorexia—Pregabalin—epilepsy syndrome	0.000702	0.00104	CcSEcCtD
Polythiazide—Dizziness—Carbamazepine—epilepsy syndrome	0.000701	0.00104	CcSEcCtD
Polythiazide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000701	0.00104	CcSEcCtD
Polythiazide—Headache—Clonazepam—epilepsy syndrome	0.000701	0.00104	CcSEcCtD
Polythiazide—Rash—Phenytoin—epilepsy syndrome	0.000701	0.00104	CcSEcCtD
Polythiazide—Dermatitis—Phenytoin—epilepsy syndrome	0.0007	0.00104	CcSEcCtD
Polythiazide—Rash—Oxcarbazepine—epilepsy syndrome	0.000697	0.00104	CcSEcCtD
Polythiazide—Constipation—Valproic Acid—epilepsy syndrome	0.000697	0.00104	CcSEcCtD
Polythiazide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000696	0.00104	CcSEcCtD
Polythiazide—Headache—Phenytoin—epilepsy syndrome	0.000696	0.00104	CcSEcCtD
Polythiazide—Headache—Oxcarbazepine—epilepsy syndrome	0.000692	0.00103	CcSEcCtD
Polythiazide—Nausea—Zonisamide—epilepsy syndrome	0.00069	0.00103	CcSEcCtD
Polythiazide—Dizziness—Lamotrigine—epilepsy syndrome	0.000678	0.00101	CcSEcCtD
Polythiazide—Vomiting—Carbamazepine—epilepsy syndrome	0.000674	0.001	CcSEcCtD
Polythiazide—Muscle spasms—Topiramate—epilepsy syndrome	0.000669	0.000996	CcSEcCtD
Polythiazide—Rash—Carbamazepine—epilepsy syndrome	0.000669	0.000995	CcSEcCtD
Polythiazide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000668	0.000994	CcSEcCtD
Polythiazide—Nausea—Clonazepam—epilepsy syndrome	0.000665	0.000988	CcSEcCtD
Polythiazide—Headache—Carbamazepine—epilepsy syndrome	0.000665	0.000988	CcSEcCtD
Polythiazide—Paraesthesia—Pregabalin—epilepsy syndrome	0.000661	0.000984	CcSEcCtD
Polythiazide—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000661	0.000984	CcSEcCtD
Polythiazide—Nausea—Phenytoin—epilepsy syndrome	0.00066	0.000982	CcSEcCtD
Polythiazide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000657	0.000977	CcSEcCtD
Polythiazide—Vomiting—Lamotrigine—epilepsy syndrome	0.000652	0.00097	CcSEcCtD
Polythiazide—Urticaria—Valproic Acid—epilepsy syndrome	0.000647	0.000963	CcSEcCtD
Polythiazide—Rash—Lamotrigine—epilepsy syndrome	0.000646	0.000962	CcSEcCtD
Polythiazide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000646	0.000961	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000644	0.00214	CbGpPWpGaD
Polythiazide—Anorexia—Gabapentin—epilepsy syndrome	0.000644	0.000958	CcSEcCtD
Polythiazide—Headache—Lamotrigine—epilepsy syndrome	0.000642	0.000955	CcSEcCtD
Polythiazide—Decreased appetite—Pregabalin—epilepsy syndrome	0.00064	0.000952	CcSEcCtD
Polythiazide—Agitation—Topiramate—epilepsy syndrome	0.00064	0.000952	CcSEcCtD
Polythiazide—Nausea—Carbamazepine—epilepsy syndrome	0.00063	0.000937	CcSEcCtD
Polythiazide—Constipation—Pregabalin—epilepsy syndrome	0.00063	0.000937	CcSEcCtD
Polythiazide—Vertigo—Topiramate—epilepsy syndrome	0.000625	0.00093	CcSEcCtD
Polythiazide—Leukopenia—Topiramate—epilepsy syndrome	0.000623	0.000927	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000615	0.00204	CbGpPWpGaD
Polythiazide—Nausea—Lamotrigine—epilepsy syndrome	0.000609	0.000906	CcSEcCtD
Polythiazide—Paraesthesia—Gabapentin—epilepsy syndrome	0.000606	0.000902	CcSEcCtD
Polythiazide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.0006	0.000893	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000597	0.00199	CbGpPWpGaD
Polythiazide—Decreased appetite—Gabapentin—epilepsy syndrome	0.000587	0.000873	CcSEcCtD
Polythiazide—Urticaria—Pregabalin—epilepsy syndrome	0.000585	0.00087	CcSEcCtD
Polythiazide—Asthenia—Valproic Acid—epilepsy syndrome	0.000584	0.000869	CcSEcCtD
Polythiazide—Constipation—Gabapentin—epilepsy syndrome	0.000578	0.000859	CcSEcCtD
Polythiazide—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000557	0.000829	CcSEcCtD
Polythiazide—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000556	0.000827	CcSEcCtD
Polythiazide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000543	0.000807	CcSEcCtD
Polythiazide—Anorexia—Topiramate—epilepsy syndrome	0.000542	0.000806	CcSEcCtD
Polythiazide—Dizziness—Valproic Acid—epilepsy syndrome	0.000539	0.000801	CcSEcCtD
Polythiazide—Urticaria—Gabapentin—epilepsy syndrome	0.000537	0.000798	CcSEcCtD
Polythiazide—Asthenia—Pregabalin—epilepsy syndrome	0.000528	0.000786	CcSEcCtD
Polythiazide—Vomiting—Valproic Acid—epilepsy syndrome	0.000518	0.00077	CcSEcCtD
Polythiazide—Rash—Valproic Acid—epilepsy syndrome	0.000514	0.000764	CcSEcCtD
Polythiazide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000513	0.000763	CcSEcCtD
Polythiazide—Headache—Valproic Acid—epilepsy syndrome	0.00051	0.000759	CcSEcCtD
Polythiazide—Paraesthesia—Topiramate—epilepsy syndrome	0.00051	0.000759	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000506	0.00168	CbGpPWpGaD
Polythiazide—Diarrhoea—Pregabalin—epilepsy syndrome	0.000504	0.00075	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000501	0.00167	CbGpPWpGaD
Polythiazide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000498	0.00074	CcSEcCtD
Polythiazide—Decreased appetite—Topiramate—epilepsy syndrome	0.000494	0.000735	CcSEcCtD
Polythiazide—Dizziness—Pregabalin—epilepsy syndrome	0.000487	0.000724	CcSEcCtD
Polythiazide—Constipation—Topiramate—epilepsy syndrome	0.000486	0.000723	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000485	0.00161	CbGpPWpGaD
Polythiazide—Asthenia—Gabapentin—epilepsy syndrome	0.000485	0.000721	CcSEcCtD
Polythiazide—Nausea—Valproic Acid—epilepsy syndrome	0.000484	0.00072	CcSEcCtD
Polythiazide—Vomiting—Pregabalin—epilepsy syndrome	0.000468	0.000697	CcSEcCtD
Polythiazide—Rash—Pregabalin—epilepsy syndrome	0.000464	0.000691	CcSEcCtD
Polythiazide—Dermatitis—Pregabalin—epilepsy syndrome	0.000464	0.00069	CcSEcCtD
Polythiazide—Diarrhoea—Gabapentin—epilepsy syndrome	0.000462	0.000687	CcSEcCtD
Polythiazide—Headache—Pregabalin—epilepsy syndrome	0.000461	0.000686	CcSEcCtD
Polythiazide—Urticaria—Topiramate—epilepsy syndrome	0.000451	0.000671	CcSEcCtD
Polythiazide—Dizziness—Gabapentin—epilepsy syndrome	0.000447	0.000664	CcSEcCtD
Polythiazide—Nausea—Pregabalin—epilepsy syndrome	0.000437	0.000651	CcSEcCtD
Polythiazide—Vomiting—Gabapentin—epilepsy syndrome	0.000429	0.000639	CcSEcCtD
Polythiazide—Rash—Gabapentin—epilepsy syndrome	0.000426	0.000633	CcSEcCtD
Polythiazide—Dermatitis—Gabapentin—epilepsy syndrome	0.000425	0.000633	CcSEcCtD
Polythiazide—Headache—Gabapentin—epilepsy syndrome	0.000423	0.000629	CcSEcCtD
Polythiazide—Hypersensitivity—Topiramate—epilepsy syndrome	0.000419	0.000623	CcSEcCtD
Polythiazide—Asthenia—Topiramate—epilepsy syndrome	0.000408	0.000606	CcSEcCtD
Polythiazide—Nausea—Gabapentin—epilepsy syndrome	0.000401	0.000597	CcSEcCtD
Polythiazide—Diarrhoea—Topiramate—epilepsy syndrome	0.000389	0.000578	CcSEcCtD
Polythiazide—Dizziness—Topiramate—epilepsy syndrome	0.000376	0.000559	CcSEcCtD
Polythiazide—Vomiting—Topiramate—epilepsy syndrome	0.000361	0.000537	CcSEcCtD
Polythiazide—Rash—Topiramate—epilepsy syndrome	0.000358	0.000533	CcSEcCtD
Polythiazide—Dermatitis—Topiramate—epilepsy syndrome	0.000358	0.000532	CcSEcCtD
Polythiazide—Headache—Topiramate—epilepsy syndrome	0.000356	0.000529	CcSEcCtD
Polythiazide—Nausea—Topiramate—epilepsy syndrome	0.000337	0.000502	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000304	0.00101	CbGpPWpGaD
